Symptomatic MYBPC3-associated non-obstructive hypertrophic cardiomyopathy: a plain-language guide
MYBPC3 non-obstructive hypertrophic cardiomyopathy explained simply: what the name means, causes, symptoms, diagnosis, treatment, family testing and research.
Hereditary hemorrhagic telangiectasia: a plain-language guide
Hereditary hemorrhagic telangiectasia explained in plain language: nosebleeds, AVMs, why screening matters, diagnosis, treatment, support and clinical trials.
Pulmonary hypertension: a plain-language guide
Pulmonary hypertension explained in plain language: what it is, the five groups, symptoms, diagnosis, treatment and how to think about a clinical trial.
Hypertension (high blood pressure): a plain-language guide
High blood pressure explained plainly: what the two numbers mean, why it usually causes no symptoms, how it is diagnosed and treated, and clinical trials.
Elevated lipoprotein(a): a plain-language guide
Elevated lipoprotein(a) explained in plain language: what Lp(a) is, who has it, how testing works, what treatment exists, and how to weigh a clinical trial.
Heart failure with reduced ejection fraction (HFrEF): a plain-language guide
HFrEF explained plainly: why heart failure does not mean the heart is stopping, what ejection fraction means, the four main medicines, and clinical trials.
Heart failure with preserved ejection fraction (HFpEF): a plain-language guide
HFpEF explained plainly: why the pumping looks normal while the heart has stiffened, what a normal scan really means, current treatment, and clinical trials.
BAG3-associated dilated cardiomyopathy: a plain-language guide
BAG3-associated dilated cardiomyopathy explained simply: what the gene does, inheritance, penetrance, symptoms, diagnosis, treatment, family testing, research.
Transthyretin amyloid cardiomyopathy (ATTR-CM): a plain-language guide
ATTR-CM explained plainly: the signs that should raise suspicion, how a bone scan now confirms it without a biopsy, the three approved medicines, and trials.